Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium
ConclusionsIn this large multinational CHC cohort from the East Asia, oral DAAs were highly effective and well tolerated across the region. Policies should encourage treatment for all CHC patients with DAAs in Asia with its heavy burden of HCV.
Source: Hepatology International - Category: Infectious Diseases Source Type: research
More News: Cancer & Oncology | Hepatitis | Hepatitis C | Hong Kong Health | Infectious Diseases | Japan Health | Liver | South Korea Health | Study | Taiwan Health | Urology & Nephrology | Virology